RecruitingNot applicableNCT05209776
Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
Studying Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Philippe MAURY, MDUniversity Hospital, Toulouse
- Intervention
- Peripheral immunological assessment on venous blood(biological)
- Enrollment
- 80 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- Toulouse University Hospital Center, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05209776 on ClinicalTrials.govOther trials for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT03593317Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVDHospices Civils de Lyon
- RECRUITINGPHASE1NCT06228924Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCTenaya Therapeutics
- RECRUITINGNCT03049254Mayo AVC Registry and BiobankMayo Clinic
See all trials for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant →